Review of oritavancin for the treatment of acute bacterial skin and skin structure infections
Objective: To assess critically oritavancin, a second-generation lipoglycopeptide, for the treatment of Acute Bacterial Skin and Skin Structure Infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. Method: An evaluation report of oritavanc...
Saved in:
| Main Authors: | Ana Alejandra García Robles, Eduardo López Briz, María Dolores Fraga Fuentes, Rocío Asensi Diez, Jesús Francisco Sierra Sánchez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-03-01
|
| Series: | Farmacia Hospitalaria |
| Subjects: | |
| Online Access: | http://www.aulamedica.es/fh/pdf/10807.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative in vitro activity of Delafloxacin and other antimicrobials against isolates from patients with acute bacterial skin, skin-structure infection and osteomyelitis
by: Ághata Cardoso da Silva Ribeiro, et al.
Published: (2024-11-01) -
Skin and systemic infections in children with atopic dermatitis: review of the current evidence
by: Rodrigo Lomelí-Valdez, et al.
Published: (2025-05-01) -
Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials
by: George D. Rodriguez, et al.
Published: (2024-10-01) -
Cost-analysis from real-world REDS study on dalbavancin in inpatient treatment of acute bacterial skin and skin structure infections
by: Matteo Scortichini, et al.
Published: (2025-06-01) -
Association of Bacterial Vaginosis and Skin Disorders in Patients with Autoimmune Antibody Positivity
by: Burcu Beksac, et al.
Published: (2021-08-01)